Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -9.11%-1.91B | ---- | -19.17%-1.53B | ---- | -12,035.15%-1.75B | ---- | -173.99%-1.29B | ---- | -99.39%14.66M |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | -30.72%-248.1M | ---- | -708.33%-1.06B | ---- | -47.00%-189.79M | ---- | 47.70%-131.52M | ---- | 31.22%-129.1M |
| Impairment and provisions: | ---- | -70.77%113.52M | ---- | -49.25%1.01B | ---- | 158.69%388.41M | ---- | 54.74%1.98B | ---- | 33.80%150.14M |
| -Other impairments and provisions | ---- | -11.72%51.01M | ---- | -279.47%-222.24M | ---- | -5.00%57.78M | ---- | -72.69%123.83M | ---- | -24.26%60.83M |
| Revaluation surplus: | ---- | 12.00%-184.85M | ---- | 36.70%-738.5M | ---- | 37.61%-210.06M | ---- | -100.11%-1.17B | ---- | -9.02%-336.7M |
| Asset sale loss (gain): | ---- | 80.86%-204.98M | ---- | 0.16%-1.26B | ---- | -56.14%-1.07B | ---- | 8.84%-1.26B | ---- | 46.82%-686M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 80.86%-204.98M | ---- | 0.16%-1.26B | ---- | -56.14%-1.07B | ---- | 8.84%-1.26B | ---- | 46.82%-686M |
| Depreciation and amortization: | ---- | -1.25%2.6B | ---- | 2.46%5.38B | ---- | 1.32%2.64B | ---- | 7.02%5.25B | ---- | 9.15%2.6B |
| -Amortization of intangible assets | ---- | 35.54%371.64M | ---- | 3.04%576.77M | ---- | -10.57%274.19M | ---- | 3.64%559.74M | ---- | 21.66%306.59M |
| -Other depreciation and amortization | ---- | -1.27%181.71M | ---- | -3.46%396.77M | ---- | -1.33%184.05M | ---- | 25.41%410.98M | ---- | 31.78%186.54M |
| Financial expense | ---- | -8.04%1.5B | ---- | 21.09%2.9B | ---- | 22.57%1.63B | ---- | -13.73%2.39B | ---- | -9.48%1.33B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -145.31%-2.76B | ---- | -0.39%11.69B | ---- | 13.39%6.09B | ---- | 73.86%11.73B | ---- | -30.33%5.37B |
| Accounts receivable (increase)decrease | ---- | -30.00%-6.16B | ---- | -239.55%-2.12B | ---- | -40.89%-4.74B | ---- | 245.42%1.52B | ---- | -34.48%-3.36B |
| Accounts payable increase (decrease) | ---- | 168.92%4.84B | ---- | -61.42%-20.26B | ---- | -984.52%-7.02B | ---- | -3,978.16%-12.55B | ---- | 89.30%-647.38M |
| Special items of business | ---- | 1,193.69%870.24M | ---- | 4.25%693.94M | ---- | 179.02%67.27M | ---- | 658.00%665.64M | ---- | -2,595.73%-85.12M |
| Adjustment items of business operations | 57.82%-3.99B | 43.17%-2.41B | -10.39%-5.43B | -192.82%-6.01B | -205.12%-9.46B | -198.46%-4.24B | -450.90%-4.92B | -53.34%6.48B | -31.30%9B | 14.61%4.3B |
| Net cash from operations | 57.82%-3.99B | 63.12%-1.54B | -10.39%-5.43B | -174.45%-5.32B | -205.12%-9.46B | -198.86%-4.17B | -450.90%-4.92B | -48.87%7.14B | -31.30%9B | 12.44%4.22B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 12.70%299.74M | -65.54%75.76M | 834.06%740.55M | -26.99%291.23M | -1.33%265.96M | 12.41%219.86M | 17.48%79.28M | -19.84%398.89M | -44.86%269.54M | -51.22%195.58M |
| Sale of fixed assets | 30.19%831.03M | -7.39%589.08M | -61.35%84.03M | -46.79%1.41B | -19.84%638.33M | -22.87%636.1M | -65.86%217.42M | 100.61%2.65B | -35.08%796.31M | -23.83%824.76M |
| Purchase of fixed assets | 8.19%-1.36B | 21.91%-969.59M | 6.72%-405.51M | -3.96%-3.41B | 42.05%-1.48B | 28.04%-1.24B | 48.71%-434.73M | 44.66%-3.28B | 10.36%-2.56B | 37.06%-1.73B |
| Sale of subsidiaries | 1,259.14%666.06M | 1,259.14%666.06M | --2M | --257.52M | 1,533.53%49.01M | --49.01M | ---- | ---- | -73.93%3M | ---- |
| Acquisition of subsidiaries | ---1.72B | ---1.66B | -16,229.17%-627.9M | ---- | ---- | ---- | ---3.85M | -25.30%-173.6M | ---- | ---- |
| Recovery of cash from investments | 167.87%1.87B | 429.18%768.79M | 67.00%227.12M | -11.24%2.93B | -72.24%698M | -93.92%145.28M | 18,268.56%136M | 554.30%3.31B | 55.63%2.51B | 483.70%2.39B |
| Cash on investment | 22.29%-2.43B | -22.69%-1.83B | -78.02%-1.59B | 12.08%-3.04B | -175.80%-3.12B | -111.12%-1.49B | -4,229.66%-891.33M | -59.91%-3.46B | 72.40%-1.13B | 75.43%-707.24M |
| Other items in the investment business | 48.49%-225.53M | -48.22%-292.61M | -50.32%-519.72M | -124.00%-451M | -127.02%-437.84M | -115.99%-197.42M | -130.33%-345.74M | 328.08%1.88B | 102.55%1.62B | 12.37%1.23B |
| Net cash from investment operations | 38.94%-2.07B | -40.93%-2.65B | -67.84%-2.09B | -251.67%-2.01B | -324.89%-3.39B | -185.06%-1.88B | -227.26%-1.24B | 119.67%1.32B | 132.63%1.51B | 180.40%2.21B |
| Net cash before financing | 52.83%-6.06B | 30.77%-4.19B | -21.98%-7.52B | -186.53%-7.32B | -222.33%-12.85B | -194.11%-6.05B | -359.07%-6.16B | 17.04%8.47B | 24.06%10.51B | 543.07%6.43B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 1.93%64.18B | 12.64%32.01B | -27.69%15.62B | 10.96%57.95B | 7.54%62.96B | 30.88%28.41B | 42.75%21.6B | 10.52%52.23B | 24.12%58.55B | -0.58%21.71B |
| Refund | -19.27%-58.88B | -24.97%-36.52B | 14.37%-14.5B | 10.33%-63.85B | 16.11%-49.37B | -3.78%-29.22B | -2.64%-16.94B | -4.18%-71.2B | -17.28%-58.85B | 8.52%-28.16B |
| Issuance of bonds | ---- | 43.82%9.77B | 69.34%5.93B | -26.72%21.78B | ---- | -63.27%6.79B | -30.00%3.5B | 68.70%29.72B | ---- | 65.18%18.5B |
| Dividends paid - financing | -19.75%-4.5B | 23.65%-1.9B | 6.19%-1.11B | 11.22%-4.92B | 14.72%-3.76B | 6.82%-2.49B | 9.49%-1.18B | 20.50%-5.55B | 26.57%-4.41B | 20.09%-2.67B |
| Absorb investment income | -5.22%569.6M | -15.21%509.6M | -31.84%409.6M | 307.97%662.28M | 387.29%600.98M | 382.20%600.98M | 9,736.01%600.98M | -84.11%162.34M | -72.47%123.33M | -70.66%124.63M |
| Other items of the financing business | 507.76%2.18B | 2,385.40%1.59B | 3,393.36%354.57M | 67.35%-3.21B | 1,508.91%358.53M | 100.71%64.04M | 134.73%10.15M | -203.22%-9.83B | 80.60%-25.45M | -327.34%-9.02B |
| Net cash from financing operations | -67.18%3.54B | 31.07%5.46B | -11.79%6.7B | 288.52%8.41B | 334.30%10.8B | 755.73%4.17B | 229.43%7.6B | 64.76%-4.46B | 46.96%-4.61B | 117.60%487M |
| Effect of rate | ---- | -20.65%-8.37M | 235.28%2.01M | 51.16%2.62M | 205.14%5.87M | 31.49%-6.94M | 86.21%-1.48M | 104.59%1.73M | -123.21%-5.58M | 39.78%-10.13M |
| Other items affecting net cash | --8.1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net Cash | -22.16%-2.51B | 167.49%1.27B | -156.67%-813.93M | -72.79%1.09B | -134.84%-2.05B | -127.24%-1.88B | -69.35%1.44B | 173.66%4B | 2,787.32%5.9B | 491.37%6.92B |
| Begining period cash | 7.92%14.87B | 7.92%14.87B | 8.20%14.87B | 40.96%13.78B | 40.96%13.78B | 40.96%13.78B | 40.59%13.74B | -35.88%9.78B | -35.88%9.78B | -35.88%9.78B |
| Cash at the end | 5.37%12.36B | 35.73%16.13B | -7.38%14.06B | 7.92%14.87B | -25.13%11.73B | -28.75%11.89B | 5.04%15.18B | 40.96%13.78B | 4.28%15.67B | 23.93%16.68B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.